In what's being called a "race to AI," companies across the globe are working to develop tools that help scientists accelerate drug discovery — and a Boston-based software company is helping change the landscape.

Dotmatics is developing software that allows researchers to harness massive amounts of data, uncover patterns, and even predict outcomes with greater accuracy and speed.

Stream NBC10 Boston news for free, 24/7, wherever you are. WATCH HERE

"It's like having a thousand lab technicians and lab researchers that are sitting next to each scientist, helping them find where to look," said Steve Tharp, the company's senior vice president of customer operations.

Bringing a drug to market is no small feat. It can take 10 years or more and cost over $5 billion. AI is changing the equa

See Full Page